Company research / NTRA

Natera, Inc. (NTRA)

CIK 0001604821 · Nasdaq · Services-Medical Laboratories

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Natera, Inc. reported revenue of $2.31B. Revenue grew 35.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.71B.

Key ratios (year ended 2025-12-31)

-13.4%
Operating margin
-9.0%
Net margin
-12.2%
Return on year-end equity
35.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-20

Headquarters locality: San Carlos · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$2.71B$2.31B$1.70B$1.08B$820.22M$625.49M$391.00M$302.33M$257.65M$209.62M$212.51M
Cost of Revenuen/an/an/an/an/an/an/an/a$158.08M$135.51M$134.49M
Gross Profit (computed)n/an/an/an/an/an/an/an/a$99.57M$74.12M$78.02M
R&D Expense$787.38M$624.11M$404.14M$320.68M$316.42M$264.21M$100.03M$51.36M$51.35M$50.06M$41.86M
Operating Income-$289.67M-$309.91M-$222.29M-$446.25M-$541.04M-$468.17M-$216.28M-$116.29M-$114.63M-$135.34M-$101.05M
Depreciation & Amortization$52.67M$41.76M$30.97M$24.10M$16.70M$11.25M$8.61M$7.73M$7.50M$7.14M$6.18M
EBITDA-$237.01M-$268.15M-$191.33M-$422.15M-$524.34M-$456.92M-$207.66M-$108.56M-$107.13M-$128.20M-$94.87M
Net Income-$192.35M-$208.16M-$190.43M-$434.80M-$547.80M-$471.72M-$229.74M-$124.83M-$128.15M-$137.63M-$100.33M
EPS (Diluted)n/a-$1.52-$1.53-$3.78-$5.57-$5.21-$2.84-$1.79-$2.22-$2.59-$1.95
Total Assets$2.66B$2.40B$1.66B$1.44B$1.39B$1.24B$932.15M$582.66M$268.17M$214.61M$210.68M
Total Liabilities$836.00M$685.93M$465.31M$676.37M$688.73M$583.18M$445.92M$303.94M$236.01M$189.20M$104.20M
Long-Term Debtn/an/an/a$282.94M$281.65M$280.39Mn/an/an/an/an/a
Shareholders' Equity$1.82B$1.71B$1.20B$765.33M$705.74M$653.30M$486.24M$278.71M$32.16M$25.42M$143.58M
Cash & Equivalentsn/an/an/an/a$466.00M$84.39M$48.67M$61.93M$46.41M$12.62M$15.26M
Operating Cash Flow$228.24M$215.30M$135.66M-$246.96M-$431.50M-$335.24M-$182.51M-$63.44M-$70.58M-$97.83M-$74.05M
Capital Expenditures$144.04M$106.19M$66.42M$39.20M$47.70M$41.03M$19.60M$4.97M$3.88M$9.87M$23.14M
Free Cash Flow$84.20M$109.11M$69.24M-$286.15M-$479.20M-$376.27M-$202.12M-$68.41M-$74.46M-$107.69M-$97.19M
Shares Outstanding143.61M139.69M132.65M119.58M111.25M95.14M86.22M78.00M62.08M54.04M52.66M
Weighted Average Diluted Sharesn/a136.72M124.72M115.00M98.41M90.56M81.01M69.56M57.85M53.60M51.58M
EPS (Basic)n/a-$1.52-$1.53-$3.78-$5.57-$5.21-$2.84-$1.79-$2.22-$2.58-$1.95

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView